PL1976537T3 - Materiał hemostatyczny - Google Patents

Materiał hemostatyczny

Info

Publication number
PL1976537T3
PL1976537T3 PL06831418T PL06831418T PL1976537T3 PL 1976537 T3 PL1976537 T3 PL 1976537T3 PL 06831418 T PL06831418 T PL 06831418T PL 06831418 T PL06831418 T PL 06831418T PL 1976537 T3 PL1976537 T3 PL 1976537T3
Authority
PL
Poland
Prior art keywords
hemostatic material
hemostatic
Prior art date
Application number
PL06831418T
Other languages
English (en)
Inventor
Craig Hardy
Edwin Lee Johnson
Paul Luksch
Original Assignee
Medtrade Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtrade Products Ltd filed Critical Medtrade Products Ltd
Publication of PL1976537T3 publication Critical patent/PL1976537T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06831418T 2005-12-29 2006-12-19 Materiał hemostatyczny PL1976537T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0526505.3A GB0526505D0 (en) 2005-12-29 2005-12-29 Hemostatic material
EP06831418A EP1976537B1 (en) 2005-12-29 2006-12-19 Hemostatic material
PCT/GB2006/004776 WO2007074327A1 (en) 2005-12-29 2006-12-19 Hemostatic material

Publications (1)

Publication Number Publication Date
PL1976537T3 true PL1976537T3 (pl) 2014-01-31

Family

ID=35841287

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06831418T PL1976537T3 (pl) 2005-12-29 2006-12-19 Materiał hemostatyczny

Country Status (13)

Country Link
US (1) US7981872B2 (pl)
EP (1) EP1976537B1 (pl)
AU (1) AU2006329661B2 (pl)
BR (1) BRPI0621164B8 (pl)
CA (1) CA2635381C (pl)
DK (1) DK1976537T3 (pl)
ES (1) ES2417501T3 (pl)
GB (1) GB0526505D0 (pl)
MY (1) MY148836A (pl)
PL (1) PL1976537T3 (pl)
PT (1) PT1976537E (pl)
WO (1) WO2007074327A1 (pl)
ZA (1) ZA200806606B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
BR0210406A (pt) 2001-06-14 2006-04-04 Providence Health Sys Oregon curativo de ferimento, e, métodos de controle de sangramento severo, e de produção de um curativo de ferimento capaz de controlar o sangramento severo
US9204957B2 (en) 2005-03-17 2015-12-08 Hemcon Medical Technologies, Inc. Systems and methods for hemorrhage control and or tissue repair
FR2897775B1 (fr) * 2006-02-24 2013-05-03 Elisabeth Laugier Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
JP2009538192A (ja) 2006-05-23 2009-11-05 プロビデンス ヘルス システム−オレゴン ディー／ビー／エー プロビデンス セント ビンセント メディカル センター 体の内腔または体の中空器官内に包帯構造を導入および適用するシステムおよび方法
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
AU2009241687A1 (en) * 2008-05-02 2009-11-05 Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center Wound dressing devices and methods
EP2340002B1 (en) 2008-10-06 2015-03-25 Providence Health System - Oregon Foam medical devices and methods
US20110104279A1 (en) * 2009-11-04 2011-05-05 Marraccini Philip A Healing powder and method of use thereof
CA2780898A1 (en) 2009-11-13 2011-05-19 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
TWI476018B (zh) * 2011-01-06 2015-03-11 Taiwan Textile Res Inst 微／奈米球狀止血材料及其製備方法
CA2914610C (en) 2013-03-13 2022-08-02 University Of Maryland Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
EP2968651B1 (en) * 2013-03-15 2020-10-21 Cook Medical Technologies LLC Adhesive medical products and methods for treating gastrointestinal lesions
GB2524299A (en) * 2014-03-19 2015-09-23 Medtrade Products Ltd Wound dressing
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
WO2016049203A1 (en) * 2014-09-23 2016-03-31 Loma Linda University Composition, preparation, and use of chitosan power for biomedical applications
WO2018116052A1 (en) 2016-12-20 2018-06-28 Innovative Nano & Micro Technologies Pvt Ltd (Inm Technologies), Scaffold compositions for tissue repair
TR201713929A2 (tr) 2017-09-20 2019-04-22 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari
WO2019067680A1 (en) 2017-09-27 2019-04-04 Cook Medical Technologies Llc CROSSLINKING SUBMUCOSAL INJECTION SYSTEM
CN111587129A (zh) * 2018-01-12 2020-08-25 波士顿科学国际有限公司 实现止血的粉末
US12263185B2 (en) 2018-02-05 2025-04-01 Bc3 Technologies, Inc. Hemostatic material and spray
CN115282327B (zh) * 2022-08-16 2023-11-10 常州华联医疗器械集团股份有限公司 一种湿性抗菌敷料

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56139423A (en) 1980-04-02 1981-10-30 Toyo Seiyaku Kasei Kk Hemostatic agent for dental oral use
US4394373A (en) 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
US4532134A (en) 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
IT1261474B (it) * 1993-05-07 1996-05-23 Rosa Alfredo De Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
US5420197A (en) 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
US5599916A (en) 1994-12-22 1997-02-04 Kimberly-Clark Corporation Chitosan salts having improved absorbent properties and process for the preparation thereof
US5836970A (en) * 1996-08-02 1998-11-17 The Kendall Company Hemostatic wound dressing
ZA987019B (en) 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
JP4606586B2 (ja) * 1998-11-10 2011-01-05 株式会社ネーテック 機能性キトサン誘導体
US6536448B2 (en) 2000-12-29 2003-03-25 Kimberly-Clark Worldwide, Inc. Hemostat coated dental floss and hemostat coated dental tape
BR0210406A (pt) 2001-06-14 2006-04-04 Providence Health Sys Oregon curativo de ferimento, e, métodos de controle de sangramento severo, e de produção de um curativo de ferimento capaz de controlar o sangramento severo
CA2484453A1 (en) 2002-04-23 2003-11-06 Netech Inc. Medicinal compositions containing photocrosslinkable chitosan derivative
WO2005087280A1 (en) 2004-03-11 2005-09-22 Medtrade Products Limited Compositions of alpha and beta chitosan and methods of preparing them

Also Published As

Publication number Publication date
ES2417501T3 (es) 2013-08-08
WO2007074327A1 (en) 2007-07-05
GB0526505D0 (en) 2006-02-08
US7981872B2 (en) 2011-07-19
EP1976537B1 (en) 2013-04-03
AU2006329661A1 (en) 2007-07-05
EP1976537A1 (en) 2008-10-08
MY148836A (en) 2013-06-14
BRPI0621164B8 (pt) 2021-11-23
BRPI0621164B1 (pt) 2019-10-08
PT1976537E (pt) 2013-05-22
US20090149422A1 (en) 2009-06-11
BRPI0621164A2 (pt) 2011-11-29
CA2635381C (en) 2014-02-18
AU2006329661B2 (en) 2012-10-04
CA2635381A1 (en) 2007-07-05
ZA200806606B (en) 2010-02-24
DK1976537T3 (da) 2013-07-01

Similar Documents

Publication Publication Date Title
GB0526503D0 (en) Hemostatic material
GB0526505D0 (en) Hemostatic material
GB0513552D0 (en) Bandage
IL192263A0 (en) Material
IL188682A0 (en) Hemostatic composition containing a hemostatic material
GB0514489D0 (en) Multilayer material
PL1800853T3 (pl) Materiał płyty
GB0506934D0 (en) Polymeric material
ZA200803498B (en) Photoluminescent material
GB0608938D0 (en) Particulate material
GB0616290D0 (en) Material
IL178867A0 (en) Hemostatic textile material
EP1925603A4 (en) ferrite
EP1947129A4 (en) PHOTORADIC AND PHOTOCYSTIC CURING COMPOSITION
GB0602193D0 (en) Insulating material
GB0610465D0 (en) Polymeric material
TWI315217B (en) Multifunctional material
GB0406295D0 (en) Brick-effect material
GB0501116D0 (en) Chromatographic material
GB0526179D0 (en) Hand-mouldable material
GB0504592D0 (en) Wrapping material
GB0525704D0 (en) Material preparation
GB0517370D0 (en) Layered material
PL372086A1 (pl) Materiał pokryciowy
GB2432356B (en) Material handling